Literature DB >> 15063947

Early ovarian ageing.

D Nikolaou1, A Templeton.   

Abstract

Observations from reproductive biology, epidemiology, and clinical assisted reproduction support the hypothesis that the time interval between the onset of accelerated decline of the ovarian reserve and the menopause is more or less fixed. Thus, it is estimated that women who become menopausal by the age of 45 may have experienced an accelerated decline of their fertility before the age of 32. Up to 10% of women in the general population may fall into this category, which has been described as "early ovarian ageing". Because of the long latent phase and predictable natural history, this condition is suitable for screening. High-risk groups include, women with a family history of early menopause. IVF has provided a model for the development of ovarian reserve tests, some of which appear promising as potential screening tools for the detection of early ovarian ageing in asymptomatic women in the general population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063947     DOI: 10.1016/j.ejogrb.2003.09.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment.

Authors:  Rubens Fadini; Ruggero Comi; Mario Mignini Renzini; Giovanni Coticchio; Marilena Crippa; Elena De Ponti; Mariabeatrice Dal Canto
Journal:  J Assist Reprod Genet       Date:  2011-06-15       Impact factor: 3.412

2.  Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.

Authors:  Pin-Yao Lin; Fu-Jen Huang; Fu-Tsai Kung; Hsin-Ju Chiang; Yu-Ju Lin; Yi-Chi Lin; Kuo-Chung Lan
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Implications of early menopause in women exposed to perfluorocarbons.

Authors:  Sarah S Knox; Timothy Jackson; Beth Javins; Stephanie J Frisbee; Anoop Shankar; Alan M Ducatman
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

Review 4.  Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease.

Authors:  Brittany P Rickard; Imran Rizvi; Suzanne E Fenton
Journal:  Toxicology       Date:  2021-11-10       Impact factor: 4.571

5.  Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study.

Authors:  Tsogzolmaa Dorjgochoo; Asha Kallianpur; Yu-Tang Gao; Hui Cai; Gong Yang; Honglan Li; Wei Zheng; Xiao Ou Shu
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

6.  Correlation of telomere length and telomerase activity with occult ovarian insufficiency.

Authors:  Samantha Butts; Harold Riethman; Sarah Ratcliffe; Alka Shaunik; Christos Coutifaris; Kurt Barnhart
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

7.  Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function.

Authors:  Tingfeng Fang; Zheng Su; Liangan Wang; Ping Yuan; Ruiqi Li; Nengyong Ouyang; Lingyan Zheng; Wenjun Wang
Journal:  Reprod Biol Endocrinol       Date:  2015-06-17       Impact factor: 5.211

Review 8.  An Update on Ovarian Aging and Ovarian Reserve Tests.

Authors:  Ramazan Amanvermez; Migraci Tosun
Journal:  Int J Fertil Steril       Date:  2015-12-23

9.  A comparison of the efficacy and safety of traditional Chinese medicine in preconditioning patients with diminished ovarian reserve that would undergo In Vitro fertilization: A network meta-analysis protocol.

Authors:  Xiuyun Qin; Yongping Gong; Feng Yu; Jiangquan Song; Shuangqian Dong; Ruoqian Zhang; Jianwei Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

10.  Overexpression of Uromodulin-like1 accelerates follicle depletion and subsequent ovarian degeneration.

Authors:  W Wang; Y Tang; L Ni; E Kim; T Jongwutiwes; A Hourvitz; R Zhang; H Xiong; H-C Liu; Z Rosenwaks
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.